ELAAI Framework
Explainable and likelihood aware AI framework for MRI-based pixel-level bladder tumour prediction
The ELAAI framework addresses critical challenges in medical imaging by integrating robust segmentation (MFA-Net), knowledge-driven refinement, and pixel-level likelihood prediction (SLIP-Net) for bladder tumour detection. This approach leverages normal bladder MRI scans for training, reducing reliance on scarce tumour-annotated data, and enhances transparency and reliability in clinical settings.
Executive Impact: Key Metrics at a Glance
ELAAI delivers tangible improvements in accuracy, reliability, and interpretability for medical imaging diagnostics, transforming bladder tumour detection.
0
DSC Score (Segmentation Accuracy)
0
PSR (Balanced Detection)
Reduced
False Positives/Negatives
Efficient
Data Usage (Normal Scans Only)
Explainable
Uncertainty Mapping
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
ELAAI Framework Overview
The ELAAI framework integrates three novel modules for comprehensive bladder tumour detection:
Enterprise Process Flow
MFA-Net (Bladder Segmentation)
→
Refinement Step (Irregularity Enhancement)
→
SLIP-Net (Tumour Likelihood Prediction)
Robust Segmentation with MFA-Net
91.16%
Average DSC Score for Bladder Segmentation
MFA-Net achieves a superior Dice-Sørensen Coefficient (DSC) of 91.16%, demonstrating highly precise bladder segmentation compared to state-of-the-art models. This network captures both fine and coarse morphological details, crucial for accurate bladder wall delineation even with challenging anatomies.
Adaptive Tolerance Score Refinement
The refinement step significantly enhances MFA-Net's initial binary masks by employing an Adaptive Tolerance Score (ATS) and a region-growing algorithm. This process accurately delineates inner bladder wall irregularities and sharpens boundary definitions, crucial for detecting subtle morphological abnormalities that may signify tumour development. It ensures precise bladder delineation without oversegmentation, as evidenced by improved boundary adherence in complex cases.
SLIP-Net: Pixel-Level Likelihood Prediction
SLIP-Net, leveraging a Swin Transformer with a novel Multi-Scale Deterministic Uncertainty (MSDU) head, provides pixel-level bladder tumour likelihood maps. This module quantifies uncertainty due to spatial misalignments between reference and target MRI slices, offering an explainable and trustworthy prediction mechanism. It is trained on masked MRI slice-pairs, reducing reliance on scarce tumour annotations and ensuring transparency in BT localization.
Comparison with SOTA Models
| Feature | ELAAI Framework | Traditional/Deep Learning SOTA |
|---|---|---|
| Annotation Dependency | Low (normal scans only for MFA-Net) | High (requires tumour-annotated MRIs) |
| Pixel-Level Prediction | Yes (with uncertainty) | Often lacking or less transparent |
| Segmentation Accuracy (DSC) | 0.9116 (Superior) | 0.8428 (PRANet), 0.6502 (HarDNet), 0.8996 (PGCF) |
| Transparency/Explainability | High (MSDU Head) | Limited |
| Handling Irregularities | Excellent (Refinement Step) | Varies, often struggles with complex shapes |
Clinical Reliability & Transparency
Scenario: Bladder Tumour Detection
Scenario: A radiologist uses the ELAAI framework to analyze a challenging MRI scan for bladder tumours.
Challenge: Traditional models struggle with low-contrast boundaries and subtle irregularities, leading to potential false positives or missed detections.
Solution: ELAAI's MFA-Net provides precise segmentation, and the refinement step enhances delineation of subtle features. SLIP-Net generates a pixel-level likelihood map, highlighting potential tumour regions with uncertainty quantification, giving the radiologist clear, interpretable insights.
Outcome: The radiologist gains increased confidence in identifying early-stage tumours and making informed diagnostic decisions, significantly improving patient outcomes by reducing diagnostic burden and enhancing precision.
Advanced ROI Calculator
Estimate the potential return on investment for integrating ELAAI into your clinical workflow.
Estimated Annual Savings
$0
Hours Reclaimed Annually
0
Your ELAAI Implementation Roadmap
A structured approach to integrating ELAAI into your medical imaging workflow for maximum impact.
Phase 1: Discovery & Customization (2-4 Weeks)
Understand your specific clinical needs, data infrastructure, and integration points. Tailor ELAAI's modules for optimal performance within your environment.
Phase 2: Data Integration & Model Adaptation (4-8 Weeks)
Securely integrate with your existing MRI data pipelines. Fine-tune MFA-Net and SLIP-Net using your institution's specific datasets to ensure robust and accurate predictions.
Phase 3: Pilot Deployment & Validation (3-6 Weeks)
Deploy ELAAI in a controlled pilot environment. Conduct rigorous validation with expert radiologists, gather feedback, and iterate for continuous improvement.
Phase 4: Full-Scale Integration & Monitoring (Ongoing)
Seamlessly integrate ELAAI across all relevant clinical workflows. Implement continuous monitoring and support to ensure sustained performance and maximum diagnostic impact.
Ready to Transform Your Diagnostics?
The ELAAI Framework offers a robust, explainable, and data-efficient solution for precise bladder tumour detection. Take the next step towards enhancing patient outcomes and optimizing clinical workflows.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat